Literature DB >> 7514652

Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin, and albumin: pharmacokinetic and morphological assessments.

W A Banks1, R D Broadwell.   

Abstract

Native horseradish peroxidase (HRP) and the lectin wheat germ agglutinin (WGA) conjugated to HRP are protein probes represented in the blood-brain barrier (BBB) literature for elucidating morphological routes of passage between blood and brain. We report the application of established pharmacokinetic methods, e.g., multiple-time regression analysis and capillary depletion technique, to measure and compare bidirectional rates of passage between blood and brain for radioactive iodine-labeled HRP (I-HRP), WGA-HRP (I-WGA-HRP), and the serum protein albumin (I-ALB) following administration of the probes intravenously (i.v.) or by intracerebroventricular (i.c.v.) injection in mice. The pharmacokinetic data are supplemented with light and electron microscopic analyses of HRP and WGA-HRP delivered i.v. or by i.c.v. injection. The rates of bidirectional movement between blood and brain are the same for coinjected I-HRP and I-ALB. Blood-borne HRP, unlike WGA-HRP, has unimpeded access to the CNS extracellularly through sites deficient in a BBB, such as the circumventricular organs and subarachnoid space/pial surface. Nevertheless, blood-borne I-WGA-HRP enters the brain approximately 10 times more rapidly than I-HRP and I-ALB. Separation of blood vessels from the neocortical parenchyma confirms the entry of blood-borne I-WGA-HRP to the brain and sequestration of I-WGA-HRP by cerebral endothelial cells. Nearly half the I-WGA-HRP radioactivity associated with cortical vessels is judged to be subcellular. Light microscopic results suggest the extracellular pathways into the brain available to blood-borne native HRP do not represent predominant routes of entry for blood-borne WGA-HRP. Ultrastructural analysis further suggests WGA-HRP is likely to undergo adsorptive transcytosis through cerebral endothelia from blood to brain via specific subcellular compartments within the endothelium. Entry of blood-borne I-WGA-HRP, but not of I-ALB, is stimulated with coinjected unlabeled WGA-HRP, suggesting the latter may enhance the adsorptive endocytosis of blood-borne I-WGA-HRP. With i.c.v. coinjection of I-WGA-HRP and I-ALB, I-WGA-HRP exists the brain more slowly than I-ALB. The brain to blood passage of I-WGA-HRP is nil with inclusion of unlabeled WGA-HRP, which does not alter the exist of I-ALB. Adsorptive endocytosis of i.c.v. injected WGA-HRP appears restricted largely to cells lining the ventricular cavities, e.g., ependymal and choroid plexus epithelia. In summary, the data suggest that the bidirectional rates of passage between brain and blood for native HRP are comparable to those for albumin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514652     DOI: 10.1046/j.1471-4159.1994.62062404.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

Review 1.  Endothelial vesicles in the blood-brain barrier: are they related to permeability?

Authors:  P A Stewart
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.

Authors:  Qingfeng Liu; Yehong Shen; Jie Chen; Xiaoling Gao; Chengcheng Feng; Lu Wang; Qizhi Zhang; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

3.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 4.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

6.  Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.

Authors:  Joseph A Falcone; Therese S Salameh; Xiang Yi; Benjamin J Cordy; William G Mortell; Alexander V Kabanov; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2014-07-15       Impact factor: 4.030

7.  Drug transport into the central nervous system: using newer findings about the blood-brain barriers.

Authors:  William A Banks
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

Review 8.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

9.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Authors:  Min Shi; Changqin Liu; Travis J Cook; Kristin M Bullock; Yanchun Zhao; Carmen Ginghina; Yanfei Li; Patrick Aro; Romel Dator; Chunmei He; Michael J Hipp; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; William A Banks; Jing Zhang
Journal:  Acta Neuropathol       Date:  2014-07-06       Impact factor: 17.088

10.  Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William S Sly; William A Banks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.